N1 Life

N1 Life is a biotechnology startup with a clear mission to revolutionize drug development. Founded in 2019, the company's slogan "Drug Delivery Innovation for Drug Development Revolution" encapsulates its vision to address unmet medical needs. N1 Life's team, comprised of passionate scientists and entrepreneurs, is focused on translating innovative peptide- and polymer-based drug delivery technologies to expedite the drug development process and enhance success rates. The company is not only challenging industry conventions but also marrying science and engineering to optimize drug development, deliver effective clinical products, and ultimately, save more lives. The most recent milestone for N1 Life was its $10.00M Seed Round investment on 17 April 2023. This round saw investment from notable venture capital firms including Legend Capital, Sino-Singapore Capital, and Frees Fund. Additionally, the company is headquartered in the United States, positioning itself in a hub of innovation and biotech. With its ambitious vision and strong financial backing, N1 Life is poised to disrupt the biotechnology sector with its groundbreaking drug delivery innovations.